fightingbreastcancer-header

med fusion-PrimeInsights™ Breast Panel is part of a UnitedHealthCare (UHC) Molecular Testing Program that streamlines access to molecular testing with minimal medical necessity denials. Only patients with UHC, Non-Government plans are eligible.

To participate in the payer sponsored program:

  1. Fax a completed requisition along with insurance information and a pathology report to 1-844-364-0860.
  2. med fusion will determine eligibility as defined in the following Panel Specifications.
  3. med fusion will contact the physician after eligibility has been determined to confirm that participation in the UHC Testing Program is desired.

med fusion-PrimeInsights™ Breast Panel

NGS: AKT1, ALK, BRAF, EGFR, ERBB2, ESR, FGFR1, FGFR2, GNA11, GNAQ, KIT, KRAS, MAP2K1, NRAS, PIK3CA, PTEN, ROS1

IHC: ER, PR, HER2

FISH: HER2

Histology:
Invasive Carcinoma

For Patients with Other Plans

med fusion is in-network with most major payers, including Aetna, Blue Cross / Blue Shield, Cigna, Amerigroup, etc. and we provide the following comprehensive breast cancer testing portfolio:

  • 50SEQ®
  • HER2 by FISH
  • ER, PR, HER2, Ki-67, p53, E-Cadherin and EGFR by IHC

For more information on our offering and how to place your order, contact our solid tumor hotline at:

1.972.966.7050 or 1.844.966.7050